Observation of Treatment Patterns With Lucentis® in Real-life Conditions in All Approved Indications

NCT04847895 · clinicaltrials.gov ↗

COMPLETED

Status

5500

Enrollment

INDUSTRY

Sponsor class

Conditions

Neovascular (Wet) Age-related Macular Degeneration

Interventions

DRUG: Lucentis

Sponsor

Novartis Pharmaceuticals